Luye Pharma Group LtdLuye Pharma Group Ltd - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

Other corporations in the rating peer group for Luye Pharma Group Ltd are shown. This page is a free Sustainability analysis for Luye Pharma Group Ltd. Jump to the end of this webpage for potential risks for Luye Pharma Group Ltd based on industry, geography and marketcap.

Luye Pharma Group Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.

SDG Transparency Score for Luye Pharma Group Ltd 
Low
0 - 3
Medium
4 - 6

8.0

High Impact
7 - 10
Last Score Update: 2023-07-01
What drives the score for Luye Pharma Group Ltd 
8.0

Environmental

8.0

Social

8.0

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
36Repligen Corp
8.1
High
36Zealand Pharma A/S
8.1
High
55Luye Pharma Group Ltd
8.0
High
55Abbott India Ltd
8.0
High
55Amrutanjan Health Care Ltd
8.0
High
.........
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Luye Pharma Group Ltd have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Luye Pharma Group Ltd disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Luye Pharma Group Ltd report the average age of the workforce?

LockedSign up for free to unlock

Does Luye Pharma Group Ltd reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Luye Pharma Group Ltd disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Luye Pharma Group Ltd disclose cybersecurity risks?

LockedSign up for free to unlock

Does Luye Pharma Group Ltd offer flexible work?

LockedSign up for free to unlock

Does Luye Pharma Group Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Luye Pharma Group Ltd disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Luye Pharma Group Ltd conduct supply chain audits?

LockedSign up for free to unlock

Does Luye Pharma Group Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Luye Pharma Group Ltd conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Luye Pharma Group Ltd disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Luye Pharma Group Ltd disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Luye Pharma Group Ltd disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Luye Pharma Group Ltd disclose water use targets?

LockedSign up for free to unlock

Does Luye Pharma Group Ltd have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Luye Pharma Group Ltd have a product recall in the last two years?

LockedSign up for free to unlock

Does Luye Pharma Group Ltd disclose incidents of discrimination?

LockedSign up for free to unlock

Does Luye Pharma Group Ltd allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Luye Pharma Group Ltd issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Luye Pharma Group Ltd disclose parental leave metrics?

LockedSign up for free to unlock

Does Luye Pharma Group Ltd disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Luye Pharma Group Ltd disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Luye Pharma Group Ltd disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Luye Pharma Group Ltd support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Luye Pharma Group Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Luye Pharma Group Ltd reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Luye Pharma Group Ltd involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Luye Pharma Group Ltd disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Luye Pharma Group Ltd disclose its waste policy?

LockedSign up for free to unlock

Does Luye Pharma Group Ltd report according to TCFD requirements?

LockedSign up for free to unlock

Does Luye Pharma Group Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Luye Pharma Group Ltd disclose energy use targets?

LockedSign up for free to unlock

Does Luye Pharma Group Ltd disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Luye Pharma Group Ltd have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Luye Pharma Group Ltd
These potential risks are based on the size, segment and geographies of the company.

Luye Pharma Group Ltd., an investment holding company, develops, produces, markets, and sells pharmaceutical products worldwide. The company offers Lipusu for ovarian and breast cancer; CMNa, a chemical sensitizer for cancer radiotherapy; Tiandida for ovarian or non-small cell lung cancer; Boyounuo, an injection for the treatment of various types of cancers and other solid tumors; and Xuezhikang, a lipid regulating drug for the treatment of hypercholesterolaemia. It also provides Maitongna for cerebral edema swelling by trauma or surgery, and for venous reflux disorders; Beixi, an acarbose capsule for Type 2 diabetes; Rivastigmine Transdermal Patch for the treatment of Alzheimer's disease; Fentanyl Transdermal Patch for cancer pain; Buprenorphine Transdermal Patch for chronic pain; and Seroquel and Seroquel XR for the treatment of schizophrenia and manic episodes of bipolar affective disorders, In addition, the company offers Rykindo, an injection for the treatment of schizophrenia; Tiandixin used as an adjuvant therapy for malignant tumors, hydrothorax and ascites, and respiratory infections; Yitaida for acute promyelocytic leukemia and liver cancer; Lutingnuo, a glutathione injection for toxicity and injuries caused by ionizing radiation; and Beitangning, a pioglitazone hydrochloride capsule to control blood glucose. Further, it offers Nuosen for acute upper digestive tract hemorrhage; Sailimai for the treatment of diarrhea; Apleek Transdermal Patch for contraception; Sidinuo for osteoporosis; Glucosamine hydrochloride tablets for osteoarthritis; Oulai, a compound sodium aescinate gel for local swelling; Oukai for the treatment of soft tissue swelling and venous edema; and Fengshiye for patients who have pains in bones, joints, and limbs. The company distributes and sells pharmaceutical drugs; and manufactures and sells biopharmaceutical products. Luye Pharma Group Ltd. was founded in 1994 and is headquartered in Yantai, the People's Republic of China.

Sorry!

Failed to process!